PRRSV: Interaction with other respiratory pathogens
PRRSV by itself may induce mild-to-severe respiratory disease but rarely results in mortality.
Page 5 of articles about mycoplasma
Dynamics of Mycoplasma hyorhinis infection in commercial swine herds
Knowledge of the dynamics of infection within the herd will allow implementation of better control strategies in affected herds.
Mycoplasma hyorhinis - not just a commensal
Although a commensal, M. hyorhinis may cause serious systemic disease through mechanisms that are not fully understood.
PCV2 related diseases (PCVDs): risk factors analysis
It has been shown that the efficacy of PCV2 vaccines was dramatically decreased in the context of husbandry deviations such as excess of cross-fostering, mingling at weaning or very large groups in nursery.
Pleurisy: economic impact and strategies for management in swine farms
The prevalence of pleurisy is surprisingly high among pigs at slaughter. A recent review of available data ranged from 12.5% in the UK, 26% in Spain, to 41% of individual pigs slaughtered in one Norwegian study.
PCV2 and Mycoplasma hyopneumoniae: co-infection and co-vaccination
Experimental Mhyo and PCV2 co-inoculations have resulted in somewhat divergent results.
Spray-dried animal plasma on weanling pigs administered a PCV2 and M. hyopneumoniae vaccine strategy
Early administration of spray-dried animal plasma may stimulate feed intake in weanling pigs.
Simultaneous PCV2 and Mycoplasma hyopneumoniae co-inoculation does not potentiate disease in conventional pigs
Under the conditions of the present study, concurrent inoculation of PCV2 and Mhyo did not result in potentiation of clinical signs and lesions attributed to either infection.
Clinical case: Outbreak of influenza in a PRRS and Mhyo stable herd
In July 2010 a severe respiratory disease occurred in the farm: coughing in gilts, and coughing and depression in fatteners concomitantly to an increase of the mean stillborn and mummified piglet rate in a batch of sows.
Prevalence of Mycoplasma hyopneumoniae infections at weaning age in European pig herds
To date, 64 out of the 150 tested herds (42.7%) and 175 out of the 3118 tested piglets (5.6%) tested positive for M.hyo.
A four-year summary of air filtration system efficacy for preventing airborne spread of PRRS and Mycoplasma hyopneumoniae
All filter types equally reduced the risk of airborne transmission of both pathogens, compared to non-filtered controls, supporting further application in the field.
Tiamulin hydrogen fumerate in-feed antibiotic for the control of PRDC
Under the conditions of this study, in-feed tiamulin hydrogen fumerate produces a positive clinical benefit in pigs experiencing PRDC or experimentally challenged with M hyo.
A one-night downtime period prevents the spread of PRRS and Mycoplasma hyopneumoniae by personnel and fomites
This paper summarizes observations recorded over a 4-year period regarding the ability of a 1-night period of downtime to prevent mechanical spread of PRRS and Mycoplasma hyopneumoniae between pig populations by personnel and fomites.
Controlling disease in young pigs
Mycoplasmal pneumonia and porcine circovirus are two of the costliest diseases affecting pork producers. Helping provide protection before disease exposure is critical to the success of any vaccination program.
Effect of vaccination of pigs against experimental infection with high and low virulence Mycoplasma hyopneumoniae strains
This study investigated the infection pattern and lung lesion development in pigs caused by a low and highly virulent Mycoplasma hyopneumoniae strain.
RespiSure-ONE® now registered for use in day old piglets
Canadian swine producers can now vaccinate for mycoplasma pneumonia when they process baby pigs. A new label claim makes RespiSure-ONE the only vaccine approved for administration at one day of age.